FMX Stock Analysis: Fomento Economico Mexicano | NYSE
Beverages - Brewers | NYSE, USA | Market Cap: 39.693m USD | 12M Return: 47.6% | US3444191064 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 59.2M
EPS Trend: -27.5%
Qual. Beats: 0
Rev. Trend: -89.2%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Fomento Económico Mexicano (FEMSA) is a Mexican multinational operating as a Coca-Cola franchise bottler and a diversified retail conglomerate headquartered in Monterrey, Mexico. Its beverage arm produces, markets, and distributes Coca-Cola trademark products across Latin America, including Mexico, Brazil, Argentina, and several Central and South American countries.
Beyond beverages, FEMSA operates the OXXO small-box convenience store chain in Mexico, Colombia, Peru, Chile, Brazil, and the United States, making it one of the largest convenience store operators in Latin America by store count. The company also runs OXXO GAS fuel retail stations in Mexico, a portfolio of drugstore brands in Chile, Colombia, Ecuador, and Mexico, electronic payment processing services for small and medium-sized businesses, and European small-box retail and foodvenience chains across Switzerland, Germany, Austria, Luxembourg, and the Netherlands. This diversified structure spreads revenue across multiple consumer staples categories, reducing dependence on any single business line.
Founded in 1890 and listed on the NYSE since 1998, FEMSA is classified within the Consumer Staples sector, with bottling franchises and convenience retail representing the core of its long-standing business model.
- OXXO same-store sales growth and new store expansion across Latin America
- Coca-Cola FEMSA pricing offsets sugar and aluminum input cost inflation
- Mexican peso depreciation pressures USD-translated revenue and margins
| Net Income: 1.74b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 8.79 > 1.0 |
| NWC/Revenue: 3.86% < 20% (prev 1.93%; Δ 1.93% < -1%) |
| CFO/TA 0.13 > 3% & CFO 5.74b > Net Income 1.74b |
| Net Debt (233b) to EBITDA (6.62b): 35.22 < 3 |
| Current Ratio: 1.14 > 1.5 & < 3 |
| Outstanding Shares: last quarter (341.3m) vs 12m ago -1.65% < -2% |
| Gross Margin: 40.50% > 18% (prev 40.50%; Δ 0.01% > 0.5%) |
| Asset Turnover: 107.6% > 50% (prev 517.4%; Δ -409.8% > 0%) |
| Interest Coverage Ratio: 3.94 > 6 (EBIT TTM 4.17b / Interest Expense TTM 1.06b) |
| A: 0.04 (Total Current Assets 15.6b - Total Current Liabilities 13.7b) / Total Assets 45.9b |
| B: 0.32 (Retained Earnings 14.8b / Total Assets 45.9b) |
| C: 0.09 (EBIT TTM 4.17b / Avg Total Assets 45.0b) |
| D: 0.43 (Book Value of Equity 12.4b / Total Liabilities 28.7b) |
| Altman-Z'' = 2.39 = BBB |
| DSRI: 3.0 (Receivables 2.59b/2.26b, Revenue 48.4b/228b) |
| GMI: 1.00 (GM 40.50% / 40.50%) |
| AQI: 1.12 (AQ_t 0.29 / AQ_t-1 0.26) |
| SGI: 0.21 (Revenue 48.4b / 228b) |
| TATA: -0.09 (NI 1.74b - CFO 5.74b) / TA 45.9b) |
| Beneish M = -1.88 (Cap -4..+1) = B |
As of August 18, 2026, the stock is trading at USD 117.28 with a total of 245,160 shares traded. Over the past week, the price has changed by -2.20%, over one month by -9.10%, over three months by -2.73% and over the past year by +47.64%.
Current recommended Stop Loss: 112.70 (which is 3.9% or 1.3 ATR below the current price).
Fomento Economico Mexicano has received a consensus analysts rating of 3.77. Therefore, it is recommended to hold FMX.
- StrongBuy: 3
- Buy: 4
- Hold: 6
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 133.9 | 14.2% |
P/E Trailing = 23.0257
P/E Forward = 92.5926
P/S = 0.0455
P/B = 3.2796
P/EG = 4.8628
Revenue TTM = 48.4b USD
EBIT TTM = 4.17b USD
EBITDA TTM = 6.62b USD
Long Term Debt = 125b USD (from longTermDebt, last quarter)
Short Term Debt = 1.74b USD (from shortTermDebt, last quarter)
Debt = 240b USD (corrected: LT Debt 125b + ST Debt 1.74b) + Leases 113b
Net Debt = 233b USD (calculated: Debt 240b - CCE 6.67b)
Enterprise Value = 273b USD (39.7b + Debt 240b - CCE 6.67b)
Interest Coverage Ratio = 3.94 (Ebit TTM 4.17b / Interest Expense TTM 1.06b)
EV/FCF = 77.68x (Enterprise Value 273b / FCF TTM 3.51b)
FCF Yield = 1.29% (FCF TTM 3.51b / Enterprise Value 273b)
FCF Margin = 7.26% (FCF TTM 3.51b / Revenue TTM 48.4b)
Net Margin = 3.60% (Net Income TTM 1.74b / Revenue TTM 48.4b)
Gross Margin = 40.50% ((Revenue TTM 48.4b - Cost of Revenue TTM 28.8b) / Revenue TTM)
Gross Margin QoQ = 40.09% (prev 40.47%)
Tobins Q-Ratio = 5.94 (Enterprise Value 273b / Total Assets 45.9b)
Interest Expense / Debt = 0.44% (Interest Expense 1.06b / Debt 240b)
Taxrate = 29.46% (1.07b / 3.64b)
NOPAT = 2.94b (EBIT 4.17b * (1 - 29.46%))
Current Ratio = 1.14 (Total Current Assets 15.6b / Total Current Liabilities 13.7b)
Debt / Equity = 19.35 (Debt 240b / totalStockholderEquity, last quarter 12.4b)
Debt / EBITDA = 35.22 (Net Debt 233b / EBITDA 6.62b)
Debt / FCF = 66.38 (Net Debt 233b / FCF TTM 3.51b)
Total Stockholder Equity = 12.8b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.87% (Net Income 1.74b / Total Assets 45.9b)
RoE = 13.65% (Net Income TTM 1.74b / Total Stockholder Equity 12.8b)
RoCE = 3.03% (EBIT 4.17b / Capital Employed (Equity 12.8b + L.T.Debt 125b))
RoIC = 9.33% (NOPAT 2.94b / Invested Capital 31.5b)
WACC = 1.31% (E(39.7b)/V(279b) * Re(7.31%) + D(240b)/V(279b) * Rd(0.44%) * (1-Tc(0.29)))
Discount Rate = 7.31% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -85.11 | Cagr: -51.72%
[DCF] Terminal Value 75.44% ; FCFF base≈3.51b ; Y1≈3.53b ; Y5≈3.74b
[DCF] Fair Price = N/A (negative equity: EV 58.1b - Net Debt 233b = -175b; debt exceeds intrinsic value)
EPS Correlation: -27.51 | EPS CAGR: -9.05% | SUE: 0.03 | # QB: 0
Revenue Correlation: -89.24 | Revenue CAGR: -72.00% | SUE: -0.59 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.05 | Chg30d=-5.67% | Revisions=-50% | Analysts=3
EPS current Year (2026-12-31): EPS=6.00 | Chg30d=+3.94% | Revisions=-40% | GrowthEPS=+109.9% | GrowthRev=+6.9%
EPS next Year (2027-12-31): EPS=5.20 | Chg30d=-2.99% | Revisions=-29% | GrowthEPS=-13.4% | GrowthRev=+7.7%
[Analyst] Revisions Ratio: -58% (up=1, down=8)